ArticleHeliyon2023

Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report.

Manuel Croix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.